Xcel Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Xcel Wealth Management, LLC

$364 Million
Q3 2025

A detailed history of Xcel Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Xcel Wealth Management, LLC holds 18,575 shares of BMY stock, worth $869,495. This represents 0.23% of its overall portfolio holdings.

Number of Shares

18,575

Previous 20,744 10.46%

Holding current value

$869,495

Previous $960,000 12.81%

% of portfolio

0.23%

Previous 0.29%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 29, 2025	SELL	$43.31 - $48.98 $93,939 - $106,237	-2,169 Reduced 10.46%	18,575 $837,000
Q2 2025 Jul 15, 2025	SELL	$44.12 - $59.6 $43,590 - $58,884	-988 Reduced 4.55%	20,744 $960,000
Q1 2025 Apr 28, 2025	BUY	$53.9 - $63.11 $372,610 - $436,279	6,913 Added 46.65%	21,732 $1.33 Million
Q4 2024 Feb 05, 2025	BUY	$51.92 - $59.94 $364,945 - $421,318	7,029 Added 90.23%	14,819 $838,000
Q2 2024 Jul 23, 2024	SELL	$40.25 - $52.99 $107,266 - $141,218	-2,665 Reduced 25.49%	7,790 $323,000

Q1 2024 Apr 22, 2024	SELL	$47.98 - $54.4 $72,689 - $82,416	-1,515 Reduced 12.66%	10,455 $566,000
Q4 2023 Jan 29, 2024	SELL	$48.48 - $57.85 $154,893 - $184,830	-3,195 Reduced 21.07%	11,970 $614,000
Q3 2023 Oct 17, 2023	SELL	$57.89 - $64.73 $837,726 - $936,707	-14,471 Reduced 48.83%	15,165 $880,000
Q2 2023 Jul 26, 2023	SELL	$63.71 - $70.74 $32,683 - $36,289	-513 Reduced 1.7%	29,636 $1.9 Million
Q1 2023 Apr 25, 2023	SELL	$65.71 - $74.53 $14,916 - $16,918	-227 Reduced 0.75%	30,149 $2.09 Million
Q4 2022 Jan 19, 2023	SELL	$68.48 - $81.09 $167,776 - $198,670	-2,450 Reduced 7.46%	30,376 $2.19 Million
Q3 2022 Oct 20, 2022	SELL	$0.13 - $76.84 $1,194 - $705,775	-9,185 Reduced 21.86%	32,826 $2.33 Million
Q2 2022 Jul 26, 2022	SELL	$72.62 - $79.98 $3.09 Million - $3.41 Million	-42,609 Reduced 50.35%	42,011 $3.24 Million
Q1 2022 Apr 29, 2022	SELL	$61.48 - $73.72 $5.55 Million - $6.66 Million	-90,290 Reduced 51.62%	84,620 $6.18 Million
Q4 2021 Feb 03, 2022	BUY	$53.63 - $62.52 $551,906 - $643,393	10,291 Added 6.25%	174,910 $10.9 Million
Q3 2021 Oct 21, 2021	BUY	$59.17 - $69.31 $1.58 Million - $1.85 Million	26,623 Added 19.29%	164,619 $9.74 Million
Q2 2021 Jul 15, 2021	SELL	$61.91 - $67.42 $928,340 - $1.01 Million	-14,995 Reduced 9.8%	137,996 $9.22 Million
Q1 2021 Apr 15, 2021	BUY	$59.34 - $66.74 $2.06 Million - $2.31 Million	34,645 Added 29.27%	152,991 $9.66 Million
Q4 2020 Jan 13, 2021	BUY	$57.74 - $65.43 $84,300 - $95,527	1,460 Added 1.25%	118,346 $7.34 Million
Q3 2020 Oct 27, 2020	BUY	$57.43 - $63.64 $931,227 - $1.03 Million	16,215 Added 16.11%	116,886 $7.05 Million
Q2 2020 Jul 10, 2020	BUY	$54.82 - $64.09 $1.35 Million - $1.58 Million	24,612 Added 32.36%	100,671 $5.92 Million
Q1 2020 Apr 07, 2020	BUY	$46.4 - $67.43 $2.63 Million - $3.82 Million	56,648 Added 291.83%	76,059 $4.24 Million
Q4 2019 Jan 09, 2020	BUY	$49.21 - $64.19 $955,215 - $1.25 Million	19,411 New	19,411 $1.25 Million

Others Institutions Holding BMY

# of Institutions

2,692

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xcel Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xcel Wealth Management, LLC with notifications on news.

Account

Xcel Wealth Management, LLC Bristol Myers Squibb CO Transaction History